11
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Pharmacokinetics and Tolerance of Weekly Oxygent™ Ca Infusions in the Dog

, , &
Pages 1155-1160 | Published online: 11 Jul 2009

References

  • Horsman M, Overgaard J. Overcoming tumour radiation resistance resulting from acute hypoxia. Eur J Cancer 1992; 28: 717
  • Moulder J E, Rockwell S. Hypoxic fractions of solid tumors: experimental techniques, methods of analysis, and a survey of existing data. Int J Radiat Oncol Biol Phys 1984; 10: 695
  • Overgaard J. Sensitization of hypoxic tumour cells-clinical experience. Int J Radiat Biol 1989; 56: 801
  • Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply and metabolic microenvironment of human tumors:a review. Cancer Res 1989; 49: 6449
  • Hasegawa T, Rhee J G, Levitt S H, Song C W. Increase in tumor pO2 by perfluorochemicals and carbogen. Int J Radiat Oncol Biol Phys 1987; 13: 569
  • Lustig R, McIntosh-Lowe N, Rose C, Haas J, Krasnow S, Spaulding M, Prosnitz L. Phase I/II study of fluosol-DA and 100% oxygen as an adjuvant to radiation in the treatment of advanced squamous cell tumors of the head and neck. Int J Radiat Oncol Biol Phys 1989; 16: 1587
  • Moulder J E, Fish B L. Intermittent use of a perfluorochemical emulsion (Fluosol-DA 20%) and carbogen breathing with fractionated irradiation. Int J Radiat Biol Phys 1988; 15: 1193
  • Rockwell S, Mate T P, Irvin C G, Nierenburg M. Reactions of tumors and normal tissues in mice to irradiation in the presence or absence of a perfluorochemical emulsion. Int J Radiat Oncol Biol Phys 1986; 12: 1315
  • Rose C M, Lustig R, McIntosh N, Teicher B. A clinical trial of fluosol-DA 20% in advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 1986; 12: 1325
  • Teicher B A, Rose C M. Effects of dose and scheduling on growth delay of the lewis lung carcinoma produced by the perfluorochemical emulsion, fluosol-DA. Int J Radiat Oncol Biol Phys 1986; 12: 1311
  • Arlen C, Follana R, LeBlanc M, Long C, Long D, Riess J G, Valla A. Formulation of highly concentrated fluorocarbon emulsions and assessment by near-total exchange perfusion of the conscious rat. Biomat, Art Cells & Art Organs 1988; 16: 455
  • Burgan A R, Herrick W C, Long D M, Long D C. Acute and subacute toxicity of 100% PFOB emulsion. Biomat, Art Cells & Art Organs 1988; 16: 681
  • Long D C, Riess J G, Follana R, Burgan A, Mattrey R F. Preparation and applications of highly concentrated PFOB emulsions. Biomat, Art Cells & Art Organs 1988; 16: 441
  • Rockwell S, Irvin C G, Kelley M, Hughes C S, Yabuki H, Porter E, Fischer J J. Effects of hyperbaric oxygen and a perfluorooctylbromide emulsion on the radiation responses of tumors and normal tissues in rodents. Int J Radiat Oncol Biol Phys 1992; 22: 87
  • Thomas C, Riess J G, Guichard M. Influence of the 100% w/v perfluorooctylbromide (PFOB) emulsion dose on tumour radiosensitivity. Int J Radiat Biol Phys 1991; 59: 433
  • Rockwell S, Kelley M, Irvin C G, Hughes C S, Yabuki H, Porter E, Fischer J J. Preclinical evaluation of Oxygent® as an adjunct to radiotherapy. Biomat Art Cells & Immob Biotech 1992; 20: 883
  • Holden S A, Teicher B A, Ha C, Gulshan A, Herman T S. Enhancement by perflusion emulsion (Oxygent®) and carbogen breathing of the tumor growth delay of the FSAIIC fibrosarcoma after treatment with antitumor alkylating agents. Biomat Art Cells & Immob Biotech 1992; 20: 895
  • Teicher B A, Herman T S, Menon K. Enhancement of fractionated radiation therapy by an experimental concentrated perflubron emulsion (Oxygent®) in the Lewis lung carcinoma. Biomat Art Cells & Immob Biotech 1992; 20: 899
  • Riess J G, Dalfors J L, Hanna G K, Klein D H, Krafft M-P, Pelura T J, Schutt E G. Development of highly fluid, concentrated and stable fluorocarbon emulsions for diagnosis and therapy. Biomat Art Cells & Immob Biotech 1992; 20: 839

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.